Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitors.

[1]  A. Ho,et al.  Role of histone deacetylase inhibitors in the treatment of cancer (Review). , 2004, International journal of oncology.

[2]  M. Esteller,et al.  Histone deacetylase inhibitors: Understanding a new wave of anticancer agents , 2004, International journal of cancer.

[3]  N. L. La Thangue,et al.  Histone deacetylase inhibitors open new doors in cancer therapy. , 2004, Biochemical pharmacology.

[4]  S. Izraeli,et al.  Histone deacetylase inhibitors--a new tool to treat cancer. , 2004, Cancer treatment reviews.

[5]  P. Workman,et al.  Histone modification enzymes: novel targets for cancer drugs. , 2004, Expert Opinion on Emerging Drugs.

[6]  Vigushin Dm,et al.  Targeted histone deacetylase inhibition for cancer therapy. , 2004 .

[7]  K. Glaser,et al.  Histone deacetylase inhibitors: the Abbott experience. , 2003, Current medicinal chemistry.

[8]  A. V. van Kuilenburg,et al.  Histone deacetylases (HDACs): characterization of the classical HDAC family. , 2003, The Biochemical journal.

[9]  Ettore Novellino,et al.  Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors. , 2003, Journal of medicinal chemistry.

[10]  P. Marks,et al.  Histone deacetylase inhibitors: from target to clinical trials , 2002, Expert opinion on investigational drugs.

[11]  Ricky W. Johnstone,et al.  Histone-deacetylase inhibitors: novel drugs for the treatment of cancer , 2002, Nature Reviews Drug Discovery.

[12]  M. Jung,et al.  Inhibitors of histone deacetylase as new anticancer agents. , 2001, Current medicinal chemistry.

[13]  M. Yoshida,et al.  Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells. , 2000, The Journal of antibiotics.

[14]  Wen‐Ming Yang,et al.  Histone Deacetylases Specifically Down-regulate p53-dependent Gene Activation* , 2000, The Journal of Biological Chemistry.

[15]  G Brosch,et al.  Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation. , 1999, Journal of medicinal chemistry.

[16]  S. Meng,et al.  p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells , 1998 .

[17]  I. Forbes,et al.  An Efficient Synthesis of a-Carboline-3-carboxylic Acid, Ethyl Ester (a-CCE) , 1993 .

[18]  Matty P. Weijenberg,et al.  A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.

[19]  Vigushin Dm,et al.  Histone deacetylase inhibitors in cancer treatment. , 2002 .